Answers are grounded in this paper and cite their sources.
Demonstrates enhanced protein analysis in low-cell-number samples, indicating broader application potential.
Cross-linking mass spectrometry (XL-MS) has emerged as an indispensable tool for dissecting protein conformations and protein-protein interactions (PPIs) within native biological systems. However, conventional in vivo XL-MS workflows suffer from significant sample loss during sample preparation, necessitating large input quantities of the starting material and fundamentally limiting their widespread applicability to mass-limited samples. Herein, we report the development of a tandem MICROFASP platform that uniquely integrates in vivo chemical cross-linking with seamless in situ sample preparation to drastically minimize sample loss throughout the entire workflow. Using disuccinimidyl suberate (DSS) as a model cross-linker, we systematically optimized all critical experimental parameters, including cross-linking reaction duration, lysis buffer formulation, and mass spectrometry data acquisition conditions. Without any pre-enrichment, we identified 517 intercross-linked peptides from just 10,000 K562 cells, a 3.5-fold increase relative to the state-of-the-art result with enrichment reported to date. Notably, 318 cross-linked peptides were identified from only 2500 living K562 cells. Structural mapping and PPI network analysis confirmed the validity of the identified cross-links, with over 97% of the cross-linked sites falling within the distance constraint of the DSS. This tandem MICROFASP method resolves the long-standing sensitivity limitation of in vivo XL-MS in low-cell-number samples, paving the way for systematic analysis of protein conformations and dynamic PPIs in clinical biopsies and the tumor microenvironment.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: